Share tips of the week
MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
Three to buy
Entain
(Evening Standard) The owner of Ladbrokes and Coral has shown that it was “absolutely right” to reject an £8bn bid from MGM, an operator of Las Vegas casinos, earlier this month. Online betting revenues rose by 41% in the last quarter of 2020. In the US, where a gold rush is underway for the newly opened sports betting market, revenues for its joint venture (with MGM) soared by 130% last year. For all the takeover brouhaha, the stock is still much cheaper than Flutter, Entain’s “biggest rival”. 1,275p
Micron Technology
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
(Shares) Not all US technology stocks are richly priced. The shift towards working from home and the roll-out of 5G mobile networks are driving strong global demand for semiconductors, but the pandemic has disrupted production and constrained supply. This producer of memory microchips stands to gain, with earnings per share forecast to rally by 45% this year and do even better in 2022. Given that earnings trajectory, the valuation looks “undemanding” with the shares on a 2021 price/earnings (p/e) multiple of 19.6. $80.72
Zoo Digital
(The Mail on Sunday) Streaming means that television programmes can cross borders more easily than ever before, but half of the catalogue at the likes of Netflix is in foreign languages. That is where this cloud-based subtitling and dubbing specialist comes in. It replaces studio-based dubbing with Zoom-style recording sessions, cutting costs and expanding the talent pool. Interim results to last September showed a “near-fivefold” rise in dubbing revenue. Buy. 79p
Three to sell
Anglo American
(The Sunday Telegraph) There is bold talk of a new boom in raw materials but much of the optimism already appears to be in the price at this mining giant. The shares have more than doubled since last year’s spring slump. They could yet have further to rally but the risks are rising, so on balance we think it is more prudent for investors to bank the already handsome gains. The mining industry is infamously cyclical so we “won’t push our luck”. 2,628p
Sage
(The Times) What technology rally? This accounting software specialist’s shares are selling for the same price now as they were in 2016. Its steady-as-you-go approach looks prudent to some, but more like a lack of ambition to most. A 3% dividend yield appears secure thanks to dependable income from subscriptions, which account for 68% of revenue so income investors may like the shares. But rivals Xero and Intuit have been expanding much faster and have arguably stolen a march on Sage in new growth areas. Investors “should search elsewhere”. 601p
Synairgen
(The Daily Telegraph) Shares in this biotech business have vaulted by more than 90% in the past two months because of promising early trial data on SNG001, an inhalation therapy that it is developing for Covid-19. Nevertheless, there are still plenty of regulatory and commercial hurdles to clear before the treatment reaches the market, at which stage it will be “anyone’s guess how many doses” will actually sell. As a firm with no revenues and a very volatile share price, Synairgen was always a speculative play and now looks a good time to bank profits. 171p
...and the rest
The Daily Telegraph
Reforms to leasehold rules have not made this a happy new year for the Ground Rents Income Fund, but the trust boasts a 6% dividend yield and a huge 41% discount to net asset value (NAV), so existing shareholders should stay invested (63p).
The Mail on Sunday
Countries around the world are turning against the mass use of antibiotics in livestock rearing. That is good news for consumers and even better news for natural feed-additives maker Anpario. The shares are up by 78% in a year. Take some profits but retain a stake (550p).
Investors Chronicle
“No-frills warehouse retailer” Costco’s membership model keeps customers loyal and has helped it to thrive in the face of e-commerce. This is one bricks-and-mortar operator with a bright future. Buy ($362).
Shares
Entertainment giant Walt Disney is a two-way bet: the Disney+ streaming service has flourished during lockdown, while reopening will be good for its theme parks. This is a “truly exceptional” company ($172). Asset manager Polar Capital is a high-quality, reasonably-priced business that yields 5.5% (660p). Shares in animal genetics business Genus have hit an all-time high, but positive updates mean the shares still have momentum. Buy (4,564p).
The Times
Aim-listed app Kooth works with the NHS to help children with mental health problems. The lockdown blues have driven renewed interest in digital-therapy services and there are growth opportunities as firms seek better staff mental healthcare. Buy (272p).
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge
-
The star small and mid-cap stocks income investors have overlooked
Opinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
By Thomas Moore
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Chemring Group: an explosive investment opportunity in defence
European states are raising their military spending, and Chemring Group looks well placed to profit
By Rupert Hargreaves
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves